The Food and Drug Administration (FDA) is hosting a workshop titled "Best Practices for Development and Application of Disease Progression Models," which is part of their performance commitment under the Prescription Drug User Fee Act of 2017. The workshop aims to discuss the best practices for creating disease progression models that can aid in drug development, and to explore current challenges and research needs in this area. The FDA is inviting the public to submit comments about areas of interest related to disease progression modeling to ensure a comprehensive discussion during the workshop. Comments must be submitted by March 26, 2021, and can be sent electronically or through written/paper submissions.
Simple Explanation
The FDA is having a big meeting to talk about how to make better models to understand how diseases change over time, which helps in making new medicines. They want people to share their ideas, and anyone can send in comments about this until March 26, 2021.